Long-term outcome of risankizumab in Crohn's disease: a real-world GETAID study.
Fumery M, Caron B, Hébuterne X, Altwegg R, Roblin X, Stefanescu C, Meyer A, Nachury M, Laharie D, Le Berre C, Guillo L, Biron A, Caillo L, Buisson A, Nancey S, Uzzan M, Vuitton L, Gilletta C, Geyl S, Blain A, Kirchgesner J, Ah-Soune P, Duveau N, Vidon M, Abitbol V, Paupard T, Tran-Minh ML, Defrance A, Peyrin-Biroulet L.
Fumery M, et al. Among authors: peyrin biroulet l.
Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00423-3. doi: 10.1016/j.cgh.2024.04.016. Online ahead of print.
Clin Gastroenterol Hepatol. 2024.
PMID: 38729389